))
The Shortage of Stimulant Medications for ADHD - Why It's Still a Problem Today
Manage episode 435415553 series 3588182
Content provided by Dr. Jenna Cheng, Dr. Patrick Kelly, Dr. Jenna Cheng, and Dr. Patrick Kelly. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Jenna Cheng, Dr. Patrick Kelly, Dr. Jenna Cheng, and Dr. Patrick Kelly or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, we take a quick break from attachment theory and dive into a very real, current problem we face today: the stimulant medication shortage for the treatment of ADHD. We explore the complex regulatory systems surrounding stimulants, including supply chain issues and being lumped into the category of Schedule II medications monitored by the Drug Enforcement Agency (DEA) to fight the Opioid Epidemic. The pressures from many layers of control fall on the shoulders of the pharmacist, and worst of all, the patients. Lastly, we discuss how to mitigate this shortage issue for patients, and the need for patient advocacy amongst clinicians.
3 episodes
Share
